Dr. Sarah Beggs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 Route 73 N, West Berlin, NJ 08091 Phone: 856-557-6020 |
News Archive
The new tool, the first Huntington's disease-specific quality of life instrument of its kind, aims to fully capture the impact of this complex disease on the everyday life of sufferers. By using this new tool to more accurately measure the impact of Huntington's and also any effect of therapeutic interventions, scientists will be in a better position to evaluate the usefulness of interventions on patients' everyday quality of life to see if there is actually a practical benefit. It is hoped that in this way, this tool will lead to more effective treatments.
Researchers at the Garvan Institute of Medical Research have developed a computational model to calculate 'skeletal age', a personalized estimate of an individual's risk of bone fracture and premature death.
Using a new noninvasive imaging technique, scientists said they have discovered important, fundamental differences in heart motion by age and gender.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR BioSciences Holdings, Inc., today announced that treatment with its lead compound, Homspera®, improved the survival of animals vaccinated with an experimental melanoma vaccine.
Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S. Food and Drug Administration (FDA) has granted 510K marketing clearance of the new C-Reactive Protein (CRP) assay when used by healthcare professionals in conjunction with the Piccolo Xpress™ point-of-care analyzer.
› Verified 7 days ago